Bobby Sandage Jr, PhD
President & CEO, Euclises
30+ years of experience in the pharmaceutical industry, beginning at Aeolus Pharmaceuticals. Former President & CEO of Coronado BioSciences, Inc. and VP of Covidien Pharmaceuticals’ oncology research and development program. For 19 years, Dr. Sandage was the Chief Scientific Officer and Executive Vice President of Research and Development, Quality and Manufacturing at Indevus Pharmaceuticals, which was acquired by Endo Pharmaceuticals in 2009. Prior to Indevus he held senior drug development positions at DuPont Merck Pharmaceutical Company, DuPont/American Critical Care, Merrell Dow and Dow Pharmaceuticals.